Safety of 5-hydroxy-L-tryptophan

被引:66
作者
Das, YT
Bagchi, M
Bagchi, D
Preuss, HG
机构
[1] Georgetown Univ, Med Ctr, Dept Physiol, Washington, DC 20057 USA
[2] ISSI Labs Inc, Piscataway, NJ 08854 USA
[3] Creighton Univ, Sch Pharm & Allied Hlth Profess, Dept Pharm Sci, Omaha, NE 68178 USA
关键词
5-hydroxy-L-tryptophan; 5-HTP; 5-L-HTP; 5-OH-Trp; L-tryptophan; LT; L-Trp; 5-HT; eosinophilia-myalgia syndrome; EMS; eosinophilia-myalgia syndrorne-related disorder EMS-related disorder; peak X; tryptophan-4,5-dione; L-Trp-4,5D; dietary supplement;
D O I
10.1016/j.toxlet.2003.12.070
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
5-Hydroxy-(L)-tryptophan (5-HTP) is the immediate precursor in the biosynthesis of 5-hydroxy-tryptamine (5-HT; serotonin) from the essential amino acid (L)-tryptophan ((L)-Trp). The use Of (L)-Trp as a dietary supplement was discontinued in 1989 due to an outbreak of eosinophilia-myalgia syndrome (EMS) that was traced to a contaminated synthetic (L)-Trp from a single manufacturer. 5-HTP has since become a popular dietary supplement in lieu of the removal Of (L)-Trp from the market. Because of its chemical and biochemical relationship to (L)-Trp, 5-HTP has been under vigilance by consumers, industry, academia and government for its safety. However, no definitive cases of toxicity have emerged despite the worldwide usage of 5-HTP for last 20 years, with the possible exception of one unresolved case of a Canadian woman. Extensive analyses of several sources of 5-HTP have shown no toxic contaminants similar to those associated with (L)-Trp, nor the presence of any other significant impurities. A minor chromatographic peak (peak X) reported in some 5-HTP samples lacks credibility due to chromatographic artifacts and infinitesimal concentrations, and has raised undue speculations concerning its chemistry and toxicity. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:111 / 122
页数:12
相关论文
共 91 条
[1]   IDENTIFICATION OF 4 METABOLITES OF 3-(PHENYLAMINO)ALANINE, A CONSTITUENT IN L-TRYPTOPHAN PRODUCTS IMPLICATED IN EOSINOPHILIA-MYALGIA-SYNDROME, IN RATS [J].
ADACHI, J ;
MIO, T ;
UENO, Y ;
NAITO, T ;
NISHIMURA, A ;
FUJIWARA, S ;
SUMINO, K ;
TATSUNO, Y .
ARCHIVES OF TOXICOLOGY, 1994, 68 (08) :500-505
[2]   ACCUMULATION OF 3-(PHENYLAMINO)ALANINE, A CONSTITUENT IN L-TRYPTOPHAN PRODUCTS IMPLICATED IN EOSINOPHILIA-MYALGIA-SYNDROME, IN BLOOD AND ORGANS OF THE LEWIS RATS [J].
ADACHI, J ;
GOMEZ, M ;
SMITH, CC ;
STERNBERG, EM .
ARCHIVES OF TOXICOLOGY, 1995, 69 (04) :266-270
[3]   LOW BRAIN UPTAKE OF L-[C-11]5-HYDROXYTRYPTOPHAN IN MAJOR DEPRESSION - A POSITRON EMISSION TOMOGRAPHY STUDY ON PATIENTS AND HEALTHY-VOLUNTEERS [J].
AGREN, H ;
REIBRING, L ;
HARTVIG, P ;
TEDROFF, J ;
BJURLING, P ;
HORNFELDT, K ;
ANDERSSON, Y ;
LUNDQVIST, H ;
LANGSTROM, B .
ACTA PSYCHIATRICA SCANDINAVICA, 1991, 83 (06) :449-455
[4]  
Alino J J, 1976, Int Pharmacopsychiatry, V11, P8
[5]  
ANGST J, 1977, ARCH PSYCHIAT NERVEN, V224, P175
[6]  
Arnow L E, 1938, Science, V87, P308, DOI 10.1126/science.87.2257.308
[7]   EXCESSIVE DIETARY TRYPTOPHAN ENHANCES PLASMA-LIPID PEROXIDATION IN RATS [J].
AVIRAM, M ;
COGAN, U ;
MOKADY, S .
ATHEROSCLEROSIS, 1991, 88 (01) :29-34
[8]  
BARLET P, 1973, CAH MED LYON, V50, P1985
[9]   5-OH-TRYPTOPHANE IN MIGRAINE - CLINICAL AND NEUROPHYSIOLOGICAL CONSIDERATIONS [J].
BOIARDI, A ;
CRENNA, P ;
MERATI, B ;
NEGRI, S ;
TANSINI, E ;
BUSSONE, G .
JOURNAL OF NEUROLOGY, 1981, 225 (01) :41-46
[10]  
Bono G, 1982, Adv Neurol, V33, P357